Cellsway

About:

Cellsway is developing liquid biopsy platform which uses a simple blood sample for monitoring cancer.

Website: https://cellsway.com/

Twitter/X: cellsway

Top Investors: European Union, APY Ventures, TÜBİTAK, Teknoloji Yatirim, Technology & Innovation Fund

Description:

Cellsway is a liquid biopsy company that was created to provide quick cancer CTC detection methods. The business's technology, which is minimally invasive and uses a straightforward blood sample for cancer monitoring, enables healthcare professionals to heal their patients and enhance their quality of life. focuses on the development of microfluidics and lab-on-a-chip technologies for biomedical purposes.

Total Funding Amount:

1.2M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nether Alderley, Cheshire, United Kingdom

Founded Date:

2020-01-01

Contact Email:

info(AT)cellsway.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-08-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai